Suggested impact of Nkx2-1 haploinsufficiency on BRAFV600E-induced tumor phenotypes relies on circumstantial evidence including observations of reduced NKX2-1 expression levels in early neoplastic lesions. Here, NKX2-1 is linked to neoplasm.